Divergent Wealth Advisors Aptevo Therapeutics Inc. Transaction History

Divergent Wealth Advisors

  • $546 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 31, 2023
BUY
$0.31 - $1.78 $3,100 - $17,800
10,000 New
10,000 $3,000

About Aptevo Therapeutics Inc.

APVO Quotes by TradingView
  • Ticker APVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,090,640
  • Market Cap $24.5M
  • Description
  • Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelo...
More about APVO
Track This Portfolio

Track Divergent Wealth Advisors Portfolio

Follow Divergent Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Divergent Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Divergent Wealth Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email